Watch a practical, case-based discussion with Jason Wollmuth, M.D. focused on how he approaches Protected PCI with a strong focus on hemodynamics and heart failure management before, during, and after complex intervention.
Watch: https://t.co/DJquHFljZP
In a recent webinar, Dr. Sanjog Kalra presented a comprehensive, case-based framework for strategic hemodynamic support in high-risk PCI.
Watch the full webinar here: https://t.co/Ul6T58qeBY
Patient selection matters in high-risk PCI. Elective MCS/pVAD support can enable safer, more complete revascularization when used in well-selected, PROTECT-like patients. Assess anatomy + hemodynamics + comorbidity.
https://t.co/PdlOHIs6X8
Managing high-risk Protected PCI requires careful planning before, during and after the procedure. This review outlines key considerations for procedural preparation, hemodynamic monitoring, Impella CP® with SmartAssist® support, weaning strategies and access site management to help optimize care for complex patients in the cath lab.
https://t.co/J9DJkGefi8
How do different heart pump technologies compare in clinical practice?
Navin Kapur explains why matching device physiology to patient needs is key in cardiogenic shock and high-risk intervention.
Go to https://t.co/7cNnE1nggA for more educational content.
In this on-demand Protected PCI Innovation Hour, Dr. Tyler discusses a strategy-driven approach to complex, high-risk PCI that addresses physiology alongside anatomy. Topics include patient optimization, intraprocedural tolerance monitoring, data-informed decisions on support removal versus continued support after PCI and end-of-case assessment and weaning strategy.
Watch: https://t.co/EkqVanSrLr
Members of the J&J MedTech Science Office discuss percutaneous insertion of the Impella RP Flex with SmartAssist, including femoral vs. internal jugular access selection based on anticipated duration of support, early identification of right heart failure through volume loading and CVP monitoring, timing of intervention relative to shock progression, considerations for patients with existing durable LVADs, and venous hemostasis techniques.
Watch the discussion: https://t.co/9X7zPvJtrp
How do you plan for complex, high‑risk PCI?
In this on‑demand webinar, Dr. Rajan Patel shares a case‑based approach using invasive hemodynamics and heart team planning to guide Protected PCI.
Watch now: https://t.co/LTWllGgo5W
Strategic Hemodynamic Support in High-Risk PCI: Translating Evidence into Practice
Join us for an upcoming webinar focused on advancing care for high-risk PCI patients.
Hear from Dr. Daniel Burkhoff and Dr. Navin Kapur as they discuss:
- Patient selection for Protected PCI, including risk stratification and hemodynamic assessment
- Practical strategies for high-risk revascularization, from planning to device selection
- Insights from the CHIP BCIS3 trial and real-world case scenarios
- Live Q&A
Designed for interventional cardiologists and advanced practice providers looking to strengthen decision-making and optimize patient outcomes.
Register now:
June 11th, 7 PM EST - https://t.co/evYSATIInF
June 11th, 9 PM EST - https://t.co/ClR2SYDiAW
How do you identify which patients may benefit from Protected PCI?
As part of our recent Protected PCI Innovation Hour virtual webinar series Mir Babar Basir, DO discussed understanding the goals of MCS in high-risk PCI, defining high-risk PCI populations and how to approach cumulative risk and more.
Watch on-demand here: https://t.co/UZXcOxT64n
How does Impella™ work compared to other support devices?
Dr. Navin Kapur explains how Impella™ directly unloads the left ventricle by moving blood into systemic circulation, differentiating it from IABP and VA-ECMO.
Go to https://t.co/7cNnE1nggA for more educational content.
In complex, high risk coronary disease, careful patient selection helps guide whether elective hemodynamic support can enable higher quality, more complete revascularization with less peri-procedural instability.
Evidence from PROTECT series and contemporary registries shows benefit when tMCS support is applied in well selected, PROTECT like patients.
https://t.co/dGxh91y0zO
Did you know? RESTORE EF showed patients with near normal EF (>45%) experienced an 82% relative reduction in NYHA Class III and IV symptoms and a 97% relative reduction in CCS angina Class III and IV symptoms. Learn more: https://t.co/VeZ0ABqEQC
𝐔𝐒𝐈𝐋𝐀 𝐀𝐋𝐋-𝐒𝐓𝐀𝐑 𝐆𝐀𝐌𝐄𝐃𝐀𝐘
Six Lakers will be part of tonight’s DI/DII USILA All-Star Game.
Four players earned the opportunity to compete, while Head Coach Trey Keeley and Assistant Coach Nate Reichel will coach the North Team.
ℹ️: https://t.co/ELHAn00igz
Nurses are at the heart of heart recovery and their expertise is essential when caring for the sickest patients.
That’s why we offer education designed to support nurses who care for patients supported with Impella CP® with SmartAssist®, focusing on patient monitoring, proactive management, and clinical confidence in the ICU.
Supporting nurses with the right education helps heart teams deliver consistent, high‑quality care when it matters most.
Enroll today: https://t.co/NphwQ920pb
#NationalNursesMonth #NursesWeek
Wednesday, May 6, through Tuesday, May 12, marks National Nurses Week. Thank you for your hard work, your dedication, and the sacrifices you make for us all. 🩺 ❤️🩹